Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis

40Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Extensively drug-resistant (XDR) tuberculosis (TB) poses significant management challenges as there are limited pharmacological treatment options for cure. Adjunctive resectional lung surgery decreases case-fatality rates for some patients with multidrug-resistant tuberculosis (MDR-TB), but its use has not been well documented for patients with XDR-TB. We describe 17 XDR-TB patients treated with surgery as part of their case management in Latvia during 1999-2005. One patient had no previous TB treatment history, 10 were previously treated for drug-susceptible TB and six were previously treated for MDR-TB. Mycobacterium tuberculosis isolates from the 17 patients were resistant to a mean of 9.2 drugs. Due to failure of pharmacological therapy, one due to a large cavity and one due to pulmonary haemorrhage, 15 patients were treated with surgery. Despite failure of pharmacological treatment in 15 out of 17 patients, eight (47%) were cured with adjunctive surgical treatment. Surgery should be explored as a possible treatment option for patients with XDR-TB. Copyright©ERS Journals Ltd 2009.

Cite

CITATION STYLE

APA

Dravniece, G., Cain, K. P., Holtz, T. H., Riekstina, V., Leimane, V., & Zaleskis, R. (2009). Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis. European Respiratory Journal, 34(1), 180–183. https://doi.org/10.1183/09031936.00047208

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free